At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 10 enrolled
Drug / intervention
zolipidem +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Differential Effects of Zolpidem Versus Ramelteon on Nocturnal Sleep in Pediatric Burn Patients: A Prospective, Randomized Crossover Trial With Polysomnographic Recordings
In Brief
A Phase 2 clinical trial evaluating zolipidem and ramelteon for Sleep and Burns. Completed, enrolled 10 participants across 1 site.
Detailed Summary
To examine sleep changes following therapeutic drug interventions designed to promote sleep.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
CollaboratorsChildren's Hospital Medical Center, Cincinnati
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 2007
Enrollment StartDec 2009
Primary CompletionDec 2012
Study CompletionNov 2013
TodayJul 2026
First PostedOct 4, 2007
Enrollment StartDec 1, 2009
Primary CompletionDec 1, 2012
Study CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 18.7 years ago
Interventions
zolipidemdrug
zolpidem dosed at 2200 and 0200 per feeding tube depending on randomization
ramelteondrug
ramelteon dosed at 2200 and 0200 per feeding tube depending on randomization